Philip B. Adamson's most recent trade in CVRx Inc was a trade of 62,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 62,000 | 62,000 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 41,000 | 62,840 | - | 0 | Common Stock | |
| CVRx Inc | Philip B. Adamson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 27 Feb 2026 | 1,262 | 61,578 | - | 7.9 | 9,973 | Common Stock |
| CVRx Inc | Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 20,000 | 20,000 | - | 0 | Common Stock |